Factor: Clinical Trial Results Explanation: Success or failure in clinical trials significantly impacts investor confidence and thus stock price. Positive data boosts it, while negative results can plummet it. Factor: Regulatory Approvals Explanation: Gaining approval from regulatory bodies like the FDA for Sangamo's therapies is a major catalyst, leading to price surges. Delays or rejections have the opposite effect. Factor: Partnerships & Collaborations Explanation: Establishing partnerships with larger pharmaceutical companies provides validation and funding, boosting stock value. Conversely, termination of partnerships can hurt the price. Factor: Financial Performance Explanation: Sangamo's revenue, expenses, and cash flow directly influence investor sentiment. Strong financials support the stock, while losses or dwindling cash reserves can depress it. Factor: Market Conditions Explanation: Overall market trends, particularly in the biotechnology sector, can affect SGMO's price. A bullish market often lifts all stocks, while a bearish one can drag them down. Factor: Competition Explanation: The presence of competing therapies or technologies can impact SGMO's market potential and therefore its stock price. Strong competitors may erode investor confidence.